Harvard Bioscience
HBIO • NASDAQ • Stock Fundamentals
Harvard Bioscience is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO John Duke, with a market cap of $25.6M.
Market Cap$25.6M
Employees416.0
CEOJohn Duke
CountryUnited States of America
Healthcare
Medical - Instruments & Supplies
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Harvard Bioscience FAQ
Common questions about Harvard Bioscience
Harvard Bioscience (HBIO) has a market capitalization of $25.6M and trades on NASDAQ.
Harvard Bioscience has approximately 416 employees.